EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases

Dongsheng Wu, Zhipeng Gong, Xiaohu Hao, Lunxu Liu iD

Journal of Translational Medicine · 2024

DOI: 10.1186/s12967-024-05366-6 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Translational Medicine, 2024. Verfasst von Dongsheng Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Si…. Hauptthemen laut MEDLINE: Receptors, Interleukin-6, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of inflammation can lead to multiple chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma. Interleukin-6 (IL6) is crucial in regulating the inflammatory cascade, but the causal link between IL6 signaling downregulation and respiratory diseases risk is unclear. This study uses Mendelian randomization to examine the effects of IL6R blockade on respiratory diseases. Analyzing data from 522,681 Europeans, 26 genetic variants were obtained to mimic IL6R inhibition. Our findings show that IL6R blockade significantly reduces the risk of COPD (OR = 0.71, 95% CI = 0.60–9.84) and asthma (OR = 0.82, 95% CI = 0.74–0.90), with protective trends for bronchitis, pulmonary embolism, and lung cancer. Results were consistent across methods, with no significant heterogeneity or pleiotropy. These insights suggest IL6R downregulation as a potential therapeutic target for respiratory diseases, meriting further clinical investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Interleukin-6Signal TransductionHumansGenetic Predisposition to DiseaseRisk FactorsPulmonary Disease, Chronic ObstructiveMendelian Randomization AnalysisRespiratory Tract DiseasesAsthmaRespiration Disorders

Stichwörter der Autor:innen

Interleukin-6Mendelian randomizationRespiratory diseasesTherapeutic target

Substanzen

Receptors, Interleukin-6

Autor:innen und Institutionen

  • Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.
  • Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan, China. lunxu_liu@aliyun.com.

ORCID-Profile: Lunxu Liu

Förderung

  • 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University

Zitieren

APA

Wu, D., Gong, Z., Hao, X., & Liu, L. (2024). Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases. Journal of Translational Medicine. https://doi.org/10.1186/s12967-024-05366-6

Vancouver

Wu D, Gong Z, Hao X, Liu L. Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases. Journal of Translational Medicine. 2024. doi:10.1186/s12967-024-05366-6

BibTeX
@article{Wu2024,
  author = {Wu, Dongsheng and Gong, Zhipeng and Hao, Xiaohu and Liu, Lunxu},
  title = {Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases},
  journal = {Journal of Translational Medicine},
  year = {2024},
  doi = {10.1186/s12967-024-05366-6}
}
Kostenlos starten →